Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2007 (Vol. 27, No. 7)

PLMltRNA

URL:www.ba.itb.cnr.it/PLMltRNA/
  • Links
  • Poor information organization, presentation
Yes, databases are getting more specific by the day. One need only look at the description for this one—A database for tRNA molecules and genes in mitochondria of photosynthetic eukaryotes—to realize that. Such tRNAs are not of trivial interest. They appear to be related to tRNAs in the precursors to modern day mitochondria and their distribution is not fully understood. Where there is a mystery, there are scientists trying to solve it, and where there are scientists, there is probably a website, hence PLMItRNA. We can’t observe the evolutionary changes that gave rise to modern-day tRNAs, but perhaps through sequence analysis, we can track the changes. The tools at POMItRNA are aimed at solving such mysteries—more power to the designers.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »